Inventor · disambiguated record
Uwe Schwahn
Also filed as: SCHWAHN UWE
6 granted patents·9 pending applications·23 citations·filing 2006–2024
78Inventor score
Top patents by PatentIndex Score
15 records- 0191US10995150B2Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibodyREGENERON PHARMA·Filed 2019·Granted May 4, 2021·6 cites·19 claims
- 0285US10494442B2Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9REGENERON PHARMA·Filed 2014·Granted Dec 3, 2019·9 cites·20 claims
- 0382US7863280B2Substituted 2-pyridone derivatives, method for their preparation and their use as medicamentSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Jan 4, 2011·7 cites·8 claims
- 0471US2025115669A1FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic PeptidesSANOFI SA·Filed 2024·Application pending·0 cites
- 0563US8173682B2Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)WEINTRAUB PHILIP M·Filed 2006·Granted May 8, 2012·1 cites·6 claims
- 0661US12054551B2FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptidesSANOFI SA·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 0756US2011177611A1Ligand binding domains of nuclear receptors in controllable form and methods involving the sameSANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 0853US7795278B2Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereofSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Sep 14, 2010·0 cites·10 claims
- 0952US2018244801A1Methods for inhibiting atherosclerosis by administering an inhibitor of pcsk9REGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1049US2023250147A1Glp-1r agonistic peptides with reduced activitySANOFI SA·Filed 2020·Application pending·0 cites
- 1149US2023265152A1Glp-1r agonist / fgf21 fusion proteinsSANOFI SA·Filed 2020·Application pending·0 cites
- 1248US2012282710A1Ligand binding domains of nuclear receptors in controllable form and methods involving the sameSCHWAHN UWE·Filed 2012·Application pending·0 cites
- 1343US2014065649A1Test systems and methods for identifying and characterising lipid lowering drugsSCHAEFER HANS-LUDWIG·Filed 2012·Application pending·0 cites
- 1443US2011021462A1Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereofSANOFI AVENTIS DEUTSCHLAND·Filed 2010·Application pending·0 cites
- 1539US2012202795A1Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)WEINTRAUB PHILIP M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Uwe Schwahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →